Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ausems

Showing results (151-160 of 204) with videos related to

Pageof 21
Sort By:
Public Health Genomics|June 29, 2026
Optimizing reporting and outreach for surveillance and risk-reducing surgeries for cancer genetic predisposition: Findings of a workshop organized by the International Cascade ConsortiumBardha Citaku-Qerimi, Hanna Yttring, Sofia E Andersson, et al.
Human Mutation|February 27, 2010
Quantification of sequence exchange events between PMS2 and PMS2CL provides a basis for improved mutation scanning of Lynch syndrome patientsHeleen M van der Klift, Carli M J Tops, Elsa C Bik, et al.
Breast Cancer Research : BCR|February 10, 2009
A method to assess the clinical significance of unclassified variants in the BRCA1 and BRCA2 genes based on cancer family historyEncarna B Gómez García, Jan C Oosterwijk, Maarten Timmermans, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 24, 2015
Does rapid genetic counseling and testing in newly diagnosed breast cancer patients cause additional psychosocial distress? results from a randomized clinical trialMarijke R Wevers, Margreet G E M Ausems, Senno Verhoef, et al.
The Lancet. Oncology|June 22, 2019
MRI versus mammography for breast cancer screening in women with familial risk (FaMRIsc): a multicentre, randomised, controlled trialSepideh Saadatmand, H Amarens Geuzinge, Emiel J T Rutgers, et al.
Journal of the National Cancer Institute|November 23, 2024
High-grade serous carcinoma occurring after risk-reducing salpingo-oophorectomy in BRCA1/2 germline pathogenic variant carriersIris A S Stroot, Joost Bart, Harry Hollema, et al.
Gastroenterology|November 18, 2008
Chromosome 8q23.3 and 11q23.1 variants modify colorectal cancer risk in Lynch syndromeJuul T Wijnen, Richard M Brohet, Ronald van Eijk, et al.
JAMA Oncology|July 31, 2020
Cost-effectiveness of Breast Cancer Screening With Magnetic Resonance Imaging for Women at Familial RiskH Amarens Geuzinge, Inge-Marie Obdeijn, Emiel J T Rutgers, et al.
Prostate Cancer and Prostatic Diseases|December 5, 2024
Experience of urologists, oncologists and nurse practitioners with mainstream genetic testing in metastatic prostate cancerMichiel Vlaming, Margreet G E M Ausems, Lambertus A L M Kiemeney, et al.
Journal of Medical Genetics|January 14, 2018
Role of germline aberrations affecting <i>CTNNA1</i>, <i>MAP3K6</i> and <i>MYD88</i> in gastric cancer susceptibilityRobbert D A Weren, Rachel S van der Post, Ingrid P Vogelaar, et al.
Pageof 21

Showing results (151-160 of 204) with videos related to

Sort By:
Pageof 21
Public Health Genomics|June 29, 2026
Optimizing reporting and outreach for surveillance and risk-reducing surgeries for cancer genetic predisposition: Findings of a workshop organized by the International Cascade ConsortiumBardha Citaku-Qerimi, Hanna Yttring, Sofia E Andersson, et al.
Human Mutation|February 27, 2010
Quantification of sequence exchange events between PMS2 and PMS2CL provides a basis for improved mutation scanning of Lynch syndrome patientsHeleen M van der Klift, Carli M J Tops, Elsa C Bik, et al.
Breast Cancer Research : BCR|February 10, 2009
A method to assess the clinical significance of unclassified variants in the BRCA1 and BRCA2 genes based on cancer family historyEncarna B Gómez García, Jan C Oosterwijk, Maarten Timmermans, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 24, 2015
Does rapid genetic counseling and testing in newly diagnosed breast cancer patients cause additional psychosocial distress? results from a randomized clinical trialMarijke R Wevers, Margreet G E M Ausems, Senno Verhoef, et al.
The Lancet. Oncology|June 22, 2019
MRI versus mammography for breast cancer screening in women with familial risk (FaMRIsc): a multicentre, randomised, controlled trialSepideh Saadatmand, H Amarens Geuzinge, Emiel J T Rutgers, et al.
Journal of the National Cancer Institute|November 23, 2024
High-grade serous carcinoma occurring after risk-reducing salpingo-oophorectomy in BRCA1/2 germline pathogenic variant carriersIris A S Stroot, Joost Bart, Harry Hollema, et al.
Gastroenterology|November 18, 2008
Chromosome 8q23.3 and 11q23.1 variants modify colorectal cancer risk in Lynch syndromeJuul T Wijnen, Richard M Brohet, Ronald van Eijk, et al.
JAMA Oncology|July 31, 2020
Cost-effectiveness of Breast Cancer Screening With Magnetic Resonance Imaging for Women at Familial RiskH Amarens Geuzinge, Inge-Marie Obdeijn, Emiel J T Rutgers, et al.
Prostate Cancer and Prostatic Diseases|December 5, 2024
Experience of urologists, oncologists and nurse practitioners with mainstream genetic testing in metastatic prostate cancerMichiel Vlaming, Margreet G E M Ausems, Lambertus A L M Kiemeney, et al.
Journal of Medical Genetics|January 14, 2018
Role of germline aberrations affecting <i>CTNNA1</i>, <i>MAP3K6</i> and <i>MYD88</i> in gastric cancer susceptibilityRobbert D A Weren, Rachel S van der Post, Ingrid P Vogelaar, et al.
Pageof 21